Search Results for "Single And Double Blind Drug Isotretinoin"
Original Source: Rosacea Treatment with Intermediate-dose Isotretinoin: Follow-up with Erythema and Sebum Measurements.
Isotretinoin is one of the therapeutic options for rosacea. However, the response of erythema to treatment with isotretinoin is usually slow and incomplete with common (0.5-1 mg/kg/day) or low (10 mg/day) doses. This study investigated the efficacy of, and relapse on, 20 mg/day isotretinoin treatment in rosacea, with the aid of instrumental measurement of facial erythema and sebum levels. A 20 mg/day dose of isotretinoin was given for 4 months, and then the dose was tapered off within the following 6 months...
Matching Channels
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in e...
Verona’s lead drug, RPL554, is a dual phosphodiesterase (PDE) 3 and 4 inhibitor being developed as a novel treatment for chronic obstructive airways disease as COPD (chronic obstructive pulmon...
Drug Discovery - news, views, blogs and reports
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed. In the past most drugs have been discovered either by identi...
Matching News
Cipher rockets on Ranbaxy US win for Isotretinoin drug; launching 4Q
Indian drug maker Ranbaxy Laboratories won the US FDA's OK to market Absorica, a patented formulation of isotretinoin, as a treatment for severe recalcitrant nodular acne. Ranbaxy is expected to la...
Isotretinoin associated with eye infection risk
Teens whose acne is treated with isotretinoin may face twice the risk of eye infections, including conjunctivitis and styes, researchers say.
FDA Approves Cip-Isotretinoin for Acne
Cipher Pharmaceuticals' novel, patented brand formulation of the acne medication isotretinoin will reach the US market later this year under the brand name Absorica, the company says. Medscape Medic...
Isotretinoin does not increase risk of inflammatory bowel disease
Doctors should not be discouraged from prescribing isotretinoin to adolescents for inflammatory acne, according to a new study by Canadian and U.S. scientists showing the drug does not increase the ri...
Isotretinoin for Severe Acne Vulgaris: Is More Better?
This best evidence review covers a study that looked at high-dose isotretinoin for severe acne and suggests that more work needs to be done. Medscape Family Medicine
Ranbaxy launches isotretinoin product in U.S.
Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.
Low-dose isotretinoin works for adult acne
Low-dose isotretinoin may be effective, with fewer side effects, when used to treat adult acne, results of a clinical trial presented at the annual congress of the European Academy of Dermatology...
Ranbaxy Launches Absoricatm (Isotretinoin) Capsules in the U.S. Healthcare Market
Gurgaon, India, November 26, 2012 Ranbaxy Laboratories, Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced the sales and promotion launch of Absorica (Isotret...
Matching PubMed Articles
BACKGROUND: Despite acne persisting into adulthood in up to 50% of the population, very few therapeutic studies have been performed in this age group. OBJECTIVES: To assess the efficacy of 5 mg/day i...
Possible aggravation of a henoch schoenlein purpura by isotretinoin.
We report on a 16 year old patient with a hemorrhagic bullous form of a Henoch-Schönlein purpura. The cause for the event could not be determined, but the patient recovered without complications. Sin...
Abstract Objective: To determine whether OCPs are underutilized in the treatment of acne in women of reproductive age, how use of OCPs compared to use of isotretinoin, and whether adequate use and doc...
Rosacea : Systemic therapy with retinoids.
Systemic isotretinoin has been known for decades as an effective and safe therapeutic option in the treatment of severe and refractory forms of rosacea. It can also be used in special treatment-resist...
Important Controversies Associated with Isotretinoin Therapy for Acne.
Isotretinoin is a remarkably effective drug for severe, recalcitrant acne vulgaris. Soon after the drug's release in the early 1980s, a number of important adverse effects were reported subsequently l...
